Ying Gu

1.1k total citations
28 papers, 879 citations indexed

About

Ying Gu is a scholar working on Immunology, Periodontics and Cancer Research. According to data from OpenAlex, Ying Gu has authored 28 papers receiving a total of 879 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Immunology, 13 papers in Periodontics and 4 papers in Cancer Research. Recurrent topics in Ying Gu's work include Oral microbiology and periodontitis research (13 papers), Immune Response and Inflammation (9 papers) and Neutrophil, Myeloperoxidase and Oxidative Mechanisms (4 papers). Ying Gu is often cited by papers focused on Oral microbiology and periodontitis research (13 papers), Immune Response and Inflammation (9 papers) and Neutrophil, Myeloperoxidase and Oxidative Mechanisms (4 papers). Ying Gu collaborates with scholars based in United States, China and Finland. Ying Gu's co-authors include Lorne M. Golub, Fiemu E. Nwariaku, Lance S. Terada, Ru Feng Wu, You Xu, Maria Ryan, Hsi‐Ming Lee, Timo Sorsa, Clay Walker and Francis Johnson and has published in prestigious journals such as Journal of Biological Chemistry, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Ying Gu

28 papers receiving 861 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ying Gu United States 17 297 265 247 140 96 28 879
Chaolun Li China 15 253 0.9× 239 0.9× 165 0.7× 62 0.4× 75 0.8× 30 830
Ikuko Hosokawa Japan 17 223 0.8× 243 0.9× 317 1.3× 87 0.6× 149 1.6× 50 830
Morgana Rodrigues Guimarães Brazil 17 452 1.5× 286 1.1× 119 0.5× 59 0.4× 94 1.0× 37 1.0k
Rui Lü China 19 500 1.7× 236 0.9× 167 0.7× 73 0.5× 121 1.3× 66 1.0k
Anita M. Tuomainen Finland 14 333 1.1× 158 0.6× 145 0.6× 113 0.8× 207 2.2× 21 860
Chi‐Yuan Hong Taiwan 25 256 0.9× 477 1.8× 164 0.7× 114 0.8× 313 3.3× 51 1.4k
Lingxin Zhu China 21 109 0.4× 551 2.1× 175 0.7× 56 0.4× 115 1.2× 50 1.3k
Yuka Hiroshima Japan 18 233 0.8× 382 1.4× 224 0.9× 90 0.6× 45 0.5× 47 740
Ruiqing Wu China 12 115 0.4× 345 1.3× 350 1.4× 126 0.9× 85 0.9× 19 929
Yonghua Guo China 12 336 1.1× 264 1.0× 90 0.4× 66 0.5× 107 1.1× 27 746

Countries citing papers authored by Ying Gu

Since Specialization
Citations

This map shows the geographic impact of Ying Gu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ying Gu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ying Gu more than expected).

Fields of papers citing papers by Ying Gu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ying Gu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ying Gu. The network helps show where Ying Gu may publish in the future.

Co-authorship network of co-authors of Ying Gu

This figure shows the co-authorship network connecting the top 25 collaborators of Ying Gu. A scholar is included among the top collaborators of Ying Gu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ying Gu. Ying Gu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chen, Yunyun, et al.. (2023). Loss of TRIM24 promotes IL-10 expression via CBP/p300-dependent IFNβ1 transcription during macrophage activation. Inflammation Research. 72(7). 1441–1452. 1 indexed citations
2.
Golub, Lorne M., Hsi‐Ming Lee, Thomas Zimmerman, et al.. (2023). Efficacy of a Novel Pleiotropic MMP-Inhibitor, CMC2.24, in a Long-Term Diabetes Rat Model with Severe Hyperglycemia-Induced Oral Bone Loss. Journal of Inflammation Research. Volume 16. 779–792. 3 indexed citations
3.
Deng, Jie, Lorne M. Golub, Hsi‐Ming Lee, et al.. (2023). A novel modified-curcumin 2.24 resolves inflammation by promoting M2 macrophage polarization. Scientific Reports. 13(1). 15513–15513. 7 indexed citations
5.
Gu, Ying, et al.. (2021). Impact of Multidisciplinary Team Management on the Survival Rate of Head and Neck Cancer Patients: A Cohort Study Meta-analysis. Frontiers in Oncology. 11. 630906–630906. 20 indexed citations
6.
Deng, Jie, Lorne M. Golub, Hsi‐Ming Lee, et al.. (2021). A Novel Modified-Curcumin Promotes Resolvin-Like Activity and Reduces Bone Loss in Diabetes-Induced Experimental Periodontitis. Journal of Inflammation Research. Volume 14. 5337–5347. 19 indexed citations
7.
Deng, Jie, Lorne M. Golub, Hsi‐Ming Lee, et al.. (2020). <p>Chemically-Modified Curcumin 2.24: A Novel Systemic Therapy for Natural Periodontitis in Dogs</p>. Journal of Experimental Pharmacology. Volume 12. 47–60. 24 indexed citations
8.
Wang, Howard, Hsi‐Ming Lee, Veena Raja, et al.. (2019). <p>Enhanced efficacy of chemically modified curcumin in experimental periodontitis: systemic implications</p>. Journal of Experimental Pharmacology. Volume 11. 1–14. 15 indexed citations
9.
Liu, Jingxian, Liu Liu, Runjie Wu, et al.. (2019). Study of the interactions of a novel monoclonal antibody, mAb059c, with the hPD-1 receptor. Scientific Reports. 9(1). 18 indexed citations
10.
Zhang, Yazhou, Steve A. McClain, Hsi‐Ming Lee, et al.. (2016). A Novel Chemically Modified Curcumin “Normalizes” Wound-Healing in Rats with Experimentally Induced Type I Diabetes: Initial Studies. Journal of Diabetes Research. 2016. 1–11. 42 indexed citations
11.
Golub, Lorne M., Muna S. Elburki, Clay Walker, et al.. (2016). Non-antibacterial tetracycline formulations: host-modulators in the treatment of periodontitis and relevant systemic diseases. International Dental Journal. 66(3). 127–135. 60 indexed citations
12.
Hou, Jun, Ying Gu, Wei Hou, et al.. (2015). P53 codon 72 polymorphism, human papillomavirus infection, and their interaction to oral carcinoma susceptibility. BMC Genetics. 16(1). 72–72. 22 indexed citations
13.
Gu, Ying, Hsi‐Ming Lee, Yazhuo Zhang, et al.. (2013). 4-Methoxycarbonyl Curcumin: A Unique Inhibitor of Both Inflammatory Mediators and Periodontal Inflammation. Mediators of Inflammation. 2013. 1–10. 25 indexed citations
14.
Gu, Ying, Clay Walker, Maria Ryan, Jeffrey B. Payne, & Lorne M. Golub. (2012). Non-antibacterial tetracycline formulations: clinical applications in dentistry and medicine. Journal of Oral Microbiology. 4(1). 19227–19227. 74 indexed citations
15.
Gu, Ying, Hsi‐Ming Lee, Timo Sorsa, et al.. (2011). Non-antibacterial tetracyclines modulate mediators of periodontitis and atherosclerotic cardiovascular disease: A mechanistic link between local and systemic inflammation. Pharmacological Research. 64(6). 573–579. 52 indexed citations
16.
Gu, Ying, Hsi‐Ming Lee, Timo Sorsa, Sanford R. Simon, & Lorne M. Golub. (2009). Doxycyline inhibits mononuclear cell-mediated connective tissue breakdown. FEMS Immunology & Medical Microbiology. 58(2). 218–225. 22 indexed citations
17.
Gu, Ying, Rhonda F. Souza, Ru Feng Wu, You Xu, & Lance S. Terada. (2003). Induction of colonic epithelial cell apoptosis by p47‐dependent oxidants1. FEBS Letters. 540(1-3). 195–200. 4 indexed citations
18.
Wu, Ru Feng, Ying Gu, You Xu, Fiemu E. Nwariaku, & Lance S. Terada. (2003). Vascular Endothelial Growth Factor Causes Translocation of p47 to Membrane Ruffles through WAVE1. Journal of Biological Chemistry. 278(38). 36830–36840. 74 indexed citations
19.
Gu, Ying, You Xu, Ru Feng Wu, et al.. (2002). TNFα Activates c-Jun Amino Terminal Kinase through p47phox. Experimental Cell Research. 272(1). 62–74. 60 indexed citations
20.
Xu, You, Ru Feng Wu, Ying Gu, et al.. (2002). Involvement of TRAF4 in Oxidative Activation of c-Jun N-terminal Kinase. Journal of Biological Chemistry. 277(31). 28051–28057. 74 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026